JPWO2020218517A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020218517A5 JPWO2020218517A5 JP2021516265A JP2021516265A JPWO2020218517A5 JP WO2020218517 A5 JPWO2020218517 A5 JP WO2020218517A5 JP 2021516265 A JP2021516265 A JP 2021516265A JP 2021516265 A JP2021516265 A JP 2021516265A JP WO2020218517 A5 JPWO2020218517 A5 JP WO2020218517A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- particle component
- nuclear particle
- nuclear
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019084688 | 2019-04-25 | ||
| JP2019084688 | 2019-04-25 | ||
| PCT/JP2020/017710 WO2020218517A1 (ja) | 2019-04-25 | 2020-04-24 | 医薬製剤およびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020218517A1 JPWO2020218517A1 (https=) | 2020-10-29 |
| JPWO2020218517A5 true JPWO2020218517A5 (https=) | 2022-03-23 |
| JP7640453B2 JP7640453B2 (ja) | 2025-03-05 |
Family
ID=72942194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516265A Active JP7640453B2 (ja) | 2019-04-25 | 2020-04-24 | 医薬製剤およびその製造方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7640453B2 (https=) |
| WO (1) | WO2020218517A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230398107A1 (en) * | 2020-10-28 | 2023-12-14 | Kinopharma, Inc. | Pharmaceutical composition for preventing or treating viral perivaginal disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR071706A1 (es) * | 2008-05-15 | 2010-07-07 | Otsuka Pharma Co Ltd | Una formulacion farmaceutica de cilostazol solida de liberacion sostenida y metodo de preparacion. |
| JP2010189337A (ja) * | 2009-02-19 | 2010-09-02 | Asahi Breweries Ltd | 難溶性物質を含有する顆粒、錠剤、及び難溶性物質の可溶化方法 |
| JP6138635B2 (ja) | 2013-08-30 | 2017-05-31 | 旭化成株式会社 | セルロース系核粒子及びその製造方法 |
| JP7064683B2 (ja) * | 2017-01-27 | 2022-05-11 | 日本ケミファ株式会社 | 腸溶層破損防止用組成物 |
| WO2018230504A1 (ja) * | 2017-06-12 | 2018-12-20 | 富士化学工業株式会社 | 顆粒剤、並びに錠剤及びその製造方法 |
-
2020
- 2020-04-24 WO PCT/JP2020/017710 patent/WO2020218517A1/ja not_active Ceased
- 2020-04-24 JP JP2021516265A patent/JP7640453B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lavanya et al. | Pelletization technology: a quick review | |
| JP5676566B2 (ja) | マンニトールと顆粒状デンプンの圧縮性自由流動共凝集体 | |
| JP5415837B2 (ja) | 圧縮成形性に劣る粉末状の機能性物質から顆粒及び錠剤を製造する方法 | |
| JP2014516080A5 (https=) | ||
| KR101074241B1 (ko) | 장용성 고체 분산체를 포함하는 고형 제제 | |
| WO2008043167A1 (en) | Pharmaceutical compositions comprising intra- and extra- granular fractions | |
| WO2014030204A1 (ja) | 薬物含有中空粒子 | |
| JP2023514767A (ja) | 医薬組成物 | |
| JP2017122056A (ja) | 医薬含有造粒物の製造方法 | |
| JP7183403B2 (ja) | 医薬製剤およびその製造方法 | |
| CN103156860A (zh) | 一种奥氮平组合物及制备方法 | |
| Kukkar et al. | Mixing and formulation of low dose drugs: underlying problems and solutions | |
| JPWO2020218517A5 (https=) | ||
| CN104619175A (zh) | 延长释放左乙拉西坦和制备方法 | |
| JP6849007B2 (ja) | 造粒組成物、及びその製造方法 | |
| JP6308938B2 (ja) | 粒状物を製造する方法 | |
| JPWO2020218518A5 (https=) | ||
| CN106031715B (zh) | 一种盐酸多西环素缓释制剂及其制备方法 | |
| JP2013023463A (ja) | 生理活性物質含有粒子の製造方法 | |
| JP6361925B2 (ja) | 固形製剤 | |
| WO2020218517A1 (ja) | 医薬製剤およびその製造方法 | |
| JP6211044B2 (ja) | 薬物含有中空粒子 | |
| Rajkumar et al. | FORMULATION, OPTIMIZATION AND EVALUATION OF MESALAMINE TIMED RELEASE DOSAGE FORM | |
| EP4687846A1 (en) | Process for the production of a granulate and a granulate, in particular a granulate compound of excipients | |
| CZ2016573A3 (cs) | Pevná formulace abirateronu acetátu vyráběná technologií fluidní granulace |